These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21900115)

  • 1. Serum enterolactone and prognosis of postmenopausal breast cancer.
    Buck K; Vrieling A; Zaineddin AK; Becker S; Hüsing A; Kaaks R; Linseisen J; Flesch-Janys D; Chang-Claude J
    J Clin Oncol; 2011 Oct; 29(28):3730-8. PubMed ID: 21900115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
    Guglielmini P; Rubagotti A; Boccardo F
    Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
    Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
    Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
    Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
    Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
    Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
    Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R; Chang-Claude J; Linseisen J
    Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.
    Vanharanta M; Voutilainen S; Rissanen TH; Adlercreutz H; Salonen JT
    Arch Intern Med; 2003 May; 163(9):1099-104. PubMed ID: 12742810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
    Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
    Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.
    Kilkkinen A; Virtamo J; Vartiainen E; Sankila R; Virtanen MJ; Adlercreutz H; Pietinen P
    Int J Cancer; 2004 Jan; 108(2):277-80. PubMed ID: 14639615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period.
    Zeleniuch-Jacquotte A; Adlercreutz H; Akhmedkhanov A; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):885-9. PubMed ID: 9796633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
    Kilkkinen A; Erlund I; Virtanen MJ; Alfthan G; Ariniemi K; Virtamo J
    Am J Epidemiol; 2006 Apr; 163(8):687-93. PubMed ID: 16510545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
    Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary phytoestrogens and postmenopausal breast cancer risk.
    den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An incident case-referent study on plasma enterolactone and breast cancer risk.
    Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
    Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
    Jaskulski S; Jung AY; Rudolph A; Johnson T; Thöne K; Herpel E; Sinn P; Chang-Claude J
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28734033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
    Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
    Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.